Vera Therapeutics, Inc. — Director's Dealing 2021

May 14, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vera Therapeutics, Inc. (VERA)
CIK: 0001831828
Period of Report: 2021-05-13

Reporting Person: Fordyce Marshall (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	137400	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.3174	2030-01-15	Class A Common Stock (5669)		Direct
Stock Option (right to buy)	$2.8968	2030-12-15	Class A Common Stock (1107212)		Direct

Footnotes

F1: 1/3 of the shares subject to the option vested on January 10, 2021, and 1/36 of the shares vest monthly thereafter. The original grant for 9,277 shares was exercised for 3,607 shares on April 8, 2021.

F2: 1/4 of the shares subject to the option vest on December 16, 2021, and 1/48 of the shares vest monthly thereafter.